Study of a new device for heart failure with reduced pumping ability
Part of Heart & circulation clinical trials.
This trial tests a new device that creates a small shunt (passage) in the heart to help relieve pressure and improve symptoms in people with heart failure and a weak heart pump. The goal is to see if the device is safe and helpful for patients like you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have heart failure with a weak pump (ejection fraction 40% or lower).
- You have symptoms such as breathlessness or fatigue (New York Heart Association class II, III, or IVa).
- In the past year, you have had a heart failure hospitalization or needed extra diuretic medication, or in the past 6 months, you have had high levels of BNP or NT-proBNP (heart failure markers) in your blood.
- You are on stable, recommended heart failure medications (including a GLP-1 receptor agonist if appropriate) for at least 6 months.
- You do not have severe heart failure, severe valve problems, recent heart attacks or procedures, or other serious health conditions (like kidney failure or recent blood clots) listed in the exclusion criteria.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a small device placed in the heart to create a passage that may help relieve pressure and improve symptoms in people with heart failure and a weak pumping function. It aims to see if the device is safe and helpful for daily life.
This study tests a new device or procedure to help people with heart failure and a weak heart pump. If you have a low ejection fraction and are on standard medications, you may be able to join.
This study is looking at a new treatment for people with heart failure where the heart’s pumping strength is not reduced much (HFpEF or HFmrEF), but pressure inside the heart is high during exercise. It may help relieve symptoms in people who still feel unwell during normal activity despite stable standard treatment.
This study follows people with chronic heart failure to see how well an implanted device (called the Occlutech AFR) works and whether it is safe over time. It may help doctors better understand who benefits and how to manage treatment safely.
This study tests whether a CardioPulmonary Management (CPM) system device used at home is safe and can improve outcomes for people with chronic heart failure. It may help manage symptoms and reduce complications, especially for higher-risk patients.
This study evaluates how well doctors follow guidelines for treating heart failure with reduced ejection fraction (HFrEF). It aims to improve the quality of care you receive during your regular clinic visits over the next year.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.